Business Context and Reporting Period
Fortive Corporation (Fortive) filed a Form 8-K on April 1, 2019, reporting the completion of a significant acquisition. The transaction involves the purchase of Johnson & Johnson's sterilization solutions business, which focuses on low-temperature terminal sterilization and high-level disinfection.
Key Financial Metrics
- Transaction Value: Fortive paid an aggregate purchase price of $2,700,000,000.
- Adjustments: The purchase price is subject to post-closing adjustments related to the book value of inventory and certain prepaid taxes at the time of closing.
- Operational Scope: The acquired assets include rights to research, development, manufacture, marketing, distribution, and sale of the business's products.
- Financial Statements: Specific financial statements for the acquired business and pro forma financial information are not included in this filing; they are scheduled to be filed by amendment within 71 calendar days.
Material Changes
The primary material change is the formal completion of the acquisition previously announced on September 21, 2018. Fortive has now assumed the equity interests, assets, and liabilities associated with the sterilization solutions business from Ethicon, Inc. (a subsidiary of Johnson & Johnson).
Guidance, Outlook, and Risks
Management issued a press release on April 1, 2019, confirming the transaction's completion. The filing includes standard legal disclaimers regarding the Purchase Agreement, noting that representations and warranties were made solely for the benefit of the contracting parties and should not be relied upon as factual characterizations of the current state of the businesses. No specific forward-looking guidance or risk factors beyond the standard acquisition contingencies are detailed in this specific 8-K text.
Investor Verification Checklist
- Verify the final purchase price after post-closing adjustments for inventory and prepaid taxes.
- Review the upcoming pro forma financial information (due within 71 days) to assess the impact on Fortive's consolidated financial position.
- Examine the full text of the Stock and Asset Purchase Agreement (Exhibit 2.1) for specific covenants and conditions.
- Monitor the integration progress of the sterilization solutions business into Fortive's existing operations.